Free Shipping in the U.S. for orders over $1000.  Shop Now>>

Printable Datasheet

HLA-DRA (MHC II) Antibody [19-26.1; same as MB-26.1]

In Stock
Catalog Number Formulation Size Price
3122-MSM3-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$229.00
3122-MSM3-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$519.00
3122-MSM3-P1ABX
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
100ug
$519.00
Flat Rate Domestic: $60 | Orders outside the US - Contact Us for Order Information | Ships next business day
Formalin-fixed, paraffin-embedded human Tonsil stained with HLA-DRA Mouse Monoclonal Antibody (19-26.1).

Formalin-fixed, paraffin-embedded human Tonsil stained with HLA-DRA Mouse Monoclonal Antibody (19-26.1).

Flow Cytometric Analysis of Raji cells. HLA-DRA Monoclonal Antibody (19-26.1) followed by goat anti-Mouse IgG-CF488 (Blue); Isotype control (Red).

Flow Cytometric Analysis of Raji cells. HLA-DRA Monoclonal Antibody (19-26.1) followed by goat anti-Mouse IgG-CF488 (Blue); Isotype control (Red).

SDS-PAGE Analysis of Purified HLA-DRA Monoclonal Antibody (19-26.1). Confirmation of Integrity and Purity of Antibody

SDS-PAGE Analysis of Purified HLA-DRA Monoclonal Antibody (19-26.1). Confirmation of Integrity and Purity of Antibody

Applications & Dilutions

Applications Tested Dillution Protocol Note
Flow Cytometry (Flow)
1-2ug/million cells
Flow Cytometry Protocol
Immunofluorescence (IF)
1-3ug/ml
Immunohistochemistry (IHC)
1-2ug/ml
IHC Protocol
30 min at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes

Summary

This MAb reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kDa alpha (heavy) chain and a 28kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

Product Properties & Targets

Antibody Type
Mouse Monoclonals
Host
Mouse
Applications
Flow Cytometry, Immunofluorescence, Immunohistochemistry
Species Reactivity
Human
Research Areas
Cardiovascular, Immunology, B Cell Markers, Cytokine Signaling, Dendritic Cell Marker, Hematopoietic Stem Cells
Isotype / Light Chain
IgG2a / Kappa
Cellular Localization
Autolysosome membrane, Cell membrane, Early endosome membrane, Endoplasmic reticulum membrane, Late endosome membrane, Lysosome membrane
Gene Name
HLA-DRA
Positive Control
Daudi or HuT78 cells. Tonsil or lymph node., Raji, Ramos
Immunogen
Raji cells
Alternate Names
HLA class II histocompatibility antigen, DR alpha chain, MHC class II antigen DRA, DR alpha chain; HLA class II histocompatibility antigen; HLA class II histocompatibility antigen DR alpha chain; HLA DRA; HLA DRA1; HLA-DRA; HLADRA1; Major histocompatibility complex class II DR alpha; MHC cell surface glycoprotein; MHC class II antigen DRA

Database Links

Entrez Gene ID
3122
SwissProt
P01903

Additional Information

Clone
19-26.1; same as MB-26.1
Chromosome Location
6p21.3
Mol. Weight of Antigen
36kDa (α chain) and 27kDa (β chain)

Related Antibodies

View All HLA-DRA Antibodies

Functions

  • An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. This guides antigen-specific T-helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells (PubMed:29884618, PubMed:17334368, PubMed:8145819, PubMed:15322540, PubMed:22327072, PubMed:27591323, PubMed:31495665, PubMed:15265931, PubMed:9075930, PubMed:24190431). Typically presents extracellular peptide antigens of 10 to 30 amino acids that arise from proteolysis of endocytosed antigens in lysosomes (PubMed:8145819). In the tumor microenvironment, presents antigenic peptides that are primarily generated in tumor-resident APCs likely via phagocytosis of apoptotic tumor cells or macropinocytosis of secreted tumor proteins (PubMed:31495665). Presents peptides derived from intracellular proteins that are trapped in autolysosomes after macroautophagy, a mechanism especially relevant for T cell selection in the thymus and central immune tolerance (PubMed:17182262, PubMed:23783831). The selection of the immunodominant epitopes follows two processing modes: 'bind first, cut/trim later' for pathogen-derived antigenic peptides and 'cut first, bind later' for autoantigens/self-peptides (PubMed:25413013). The anchor residue at position 1 of the peptide N-terminus, usually a large hydrophobic residue, is essential for high affinity interaction with MHCII molecules (PubMed:8145819).

Key References

  • Thompson C et al. Hum Immunol 1983, 6(3):133-50
  • Rask L Autoimmunity 1991, 8(3):237-244.

PubMed Links

Storage & Stability

Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.

Reviews

There are no reviews yet.

Be the first to review “HLA-DRA (MHC II) Antibody”

Your email address will not be published. Required fields are marked *

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK
Call Us Now: 1-866-2-NEOBIO (1-866-263-6246)
NeoBiotechnologies Logo
Company Info
Antibodies
Antibody Validation
Research Areas
Resources
Newsletter Signup Updates & Sales